IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 2 filers reported holding IMPAX LABORATORIES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,890,000 | +133.6% | 200,000 | +100.0% | 1.08% | +126.7% |
| Q4 2017 | $1,665,000 | -68.5% | 100,000 | -33.3% | 0.48% | -29.0% |
| Q3 2015 | $5,282,000 | -42.5% | 150,000 | -25.0% | 0.67% | -36.9% |
| Q2 2015 | $9,184,000 | -21.6% | 200,000 | -20.0% | 1.06% | -13.7% |
| Q1 2015 | $11,718,000 | +48.0% | 250,000 | 0.0% | 1.23% | +56.0% |
| Q4 2014 | $7,920,000 | +33.6% | 250,000 | 0.0% | 0.79% | +55.4% |
| Q3 2014 | $5,928,000 | -36.2% | 250,000 | -19.4% | 0.51% | -29.0% |
| Q2 2014 | $9,297,000 | +60.0% | 310,000 | +40.9% | 0.71% | +63.8% |
| Q1 2014 | $5,812,000 | – | 220,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |